BFA Law is investigating ServiceTitan, Inc. for potential securities fraud related to its statements about developing the AI platform Max and plans to expand into new trades. The probe follows a sharp 30% drop in ServiceTitan's stock after the company reported slowing growth and decided to focus on existing trades rather than expanding. Investors may have legal options and are encouraged to contact BFA Law for more information. This investigation highlights risks around company disclosures and market reactions to strategic shifts.
The TTAN investigation alert concerning ServiceTitan's securities fraud probe provides context for readers interested in technology stocks. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 15, 2026 16:51 WIB: out of 150 priced US Technology stocks tradable on Pluang, 38 rose and 107 fell today. ASML Holding NV gained 2.78% to USD 1,618.87, while Cloudflare Inc and Accenture plc declined by 2.71% and 2.50% to USD 321.50 and USD 190.12 respectively.
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
